多重变异效应检测与自动膜片钳改善KCNH2-LQTS变异分类与心脏事件风险分层
结果显示MAVE数据可为严重功能丧失变异提供致病性很强证据,而自动膜片钳峰尾电流和贝叶斯长QT综合征外显率估计对心脏事件风险分层有显著贡献。
要点
- MAVE转运评分与自动膜片钳峰尾电流高度相关(ρ=0.69,n=433)。
- MAVE数据可为严重功能丧失变异提供致病性很强证据。
- MAVE、峰尾电流和外显率估计均与心脏事件显著相关,但MAVE在校正后两者后不再显著。
核心结论
- 高通量KCNH2 MAVE数据有助于大规模变异分类。
- 长QT综合征外显率估计和自动膜片钳峰尾电流测量有助于KCNH2错义变异杂合患者的心脏事件风险分层。
研究设计与样本
- 依据ClinGen指南校准MAVE证据强度。
- 深度表型分析1458例KCNH2错义变异杂合患者,包括QTc、心脏事件史和死亡率。
主要发现
- MAVE转运评分与自动膜片钳峰尾电流高度相关(Spearman秩相关ρ=0.69;n=433)。
- MAVE数据可为严重功能丧失变异提供致病性很强证据。
- 功能检测和贝叶斯长QT综合征外显率估计与患者性别和QTc独立建模时均显著预测心脏事件;但同时纳入峰尾电流和外显率估计时MAVE数据不再显著。
- 基于患者特异性性别和QTc的20年事件结局AUC为0.80(0.76-0.83),加入基于MAVE的前瞻性外显率评分后AUC为0.86(0.83-0.89),加入可获得的自动膜片钳峰尾电流数据后AUC为0.84(0.81-0.88)。
临床怎么用
- MAVE数据可用于KCNH2错义变异的大规模致病性分类。
- 外显率估计和自动膜片钳峰尾电流测量可用于KCNH2错义变异杂合患者的心脏事件风险分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Long QT syndrome is a lethal arrhythmia syndrome, frequently caused by rare loss-of-function variants in the potassium channel encoded by KCNH2. Variant classification is difficult, often because of lack of functional data. Moreover, variant-based risk stratification is also complicated by heterogenous clinical data and incomplete penetrance. Here we sought to test whether variant-specific information, primarily from high-throughput functional assays, could improve both classification and cardiac event risk stratification in a large, harmonized cohort of KCNH2 missense variant heterozygotes. METHODS: We quantified cell-surface trafficking of 18 796 variants in KCNH2 using a multiplexed assay of variant effect (MAVE). We recorded KCNH2 current density for 533 variants by automated patch clamping. We calibrated the strength of evidence of MAVE data according to ClinGen guidelines. We deeply phenotyped 1458 patients with KCNH2 missense variants, including QTc, cardiac event history, and mortality. We correlated variant functional data and Bayesian long QT syndrome penetrance estimates with cohort phenotypes and assessed hazard ratios for cardiac events. RESULTS: Variant MAVE trafficking scores and automated patch clamping peak tail currents were highly correlated (Spearman rank-order ρ=0.69; n=433). The MAVE data were found to provide up to pathogenic very strong evidence for severe loss-of-function variants. In the cohort, both functional assays and Bayesian long QT syndrome penetrance estimates were significantly predictive of cardiac events when independently modeled with patient sex and corrected QT interval (QTc); however, MAVE data became nonsignificant when peak tail current and penetrance estimates were also available. The area under the receiver operator characteristic curve for 20-year event outcomes based on patient-specific sex and QTc (area under the curve, 0.80 [0.76-0.83]) was improved with prospectively available penetrance scores conditioned on MAVE (area under the curve, 0.86 [0.83-0.89]) or attainable automated patch clamping peak tail current data (area under the curve, 0.84 [0.81-0.88]). CONCLUSIONS: High-throughput KCNH2 variant MAVE data meaningfully contribute to variant classification at scale, whereas long QT syndrome penetrance estimates and automated patch clamping peak tail current measurements meaningfully contribute to risk stratification of cardiac events in patients with heterozygous KCNH2 missense variants.
引用
- O'Neill MJ, Ng CA, Aizawa T, et al. Multiplexed Assays of Variant Effect and Automated Patch Clamping Improve KCNH2-LQTS Variant Classification and Cardiac Event Risk Stratification. Circulation. 2024. PMID: 39315434. doi:10.1161/CIRCULATIONAHA.124.069828
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。